Insulin Glargine vs Rituximab

## Insulin Glargine vs Rituximab: Overview

This comparison examines the pharmacological differences between **Insulin Glargine** and **Rituximab**.

## Mechanism of Action

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Insulin Glargine — 12-24 hours; Rituximab — 22 days.

## Chemical Properties

**Type**: Insulin Glargine — Protein; Rituximab — Antibody.